GRAIL, LLC (GRAL NASDAQ) stock market data APIs
$78.4379
6(7.6%)
as of October 17, 2025
Try our APIs with
free plan!
GRAIL, LLC Financial Data Overview
Price chart is built with
Anychart
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Prev. Close
78.4379
Open
84.4382
High
85.0891
Low
76.4815
52 wk Range
12.76-89.566
Market Cap
3 115 M
Shares Outstanding
36 048 K
Revenue
134 M
EPS
-3.18
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with GRAIL, LLC (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GRAIL, LLC data using free add-ons & libraries
Get GRAIL, LLC Fundamental Data
GRAIL, LLC Fundamental data includes:
- Net Revenue: 134 M
- EBITDA: -407 344 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -3.56
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GRAIL, LLC News
New
Grail Blood Test Found Seven Times More Cancers Than Standard Tests, Data Show
Grail shared the results of it Pathfinder 2 study during a meeting of the European Society for Medical Oncology in Berlin on Saturday. Continue Reading View Comments
GRAIL (GRAL) Is Up 21.5% After Samsung Partnership to Expand Galleri Test in Asia – What's Changed
Samsung C&T and Samsung Electronics announced a US$110 million equity investment in GRAIL and a collaboration to commercialize the Galleri multi-cancer detection test in key Asian markets, with initia...
Why Grail Stock Soared 14% Higher on Thursday
Key Points The cancer diagnostics specialist inked a major collaboration deal. A heavyweight Asian conglomerate will roll out its products on that continent. 10 stocks we like better than Grail › ...
Praxis Precision Medicines announces proposed public offering
* Praxis Precision Medicines (NASDAQ:PRAX [https://seekingalpha.com/symbol/PRAX]) said on Thursday it plans to offer shares of its common stock and prefunded warrants in a public offering, with all ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
